Stay updated on AT2220 Safety Study in Pompe Disease Clinical Trial

Sign up to get notified when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the AT2220 Safety Study in Pompe Disease Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page metadata has been updated to version v3.0.2 with new date stamps (2025-09-11, 2025-09-09, 2025-09) and an 'Estimated' last update label, replacing older v3.0.1 metadata from 2018. No substantive changes to core content (pricing, stock, or time slots) were detected.
    Difference
    1%
    Check dated 2025-09-14T18:45:33.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.3%
    Check dated 2025-09-07T13:21:06.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while removing specific details about previous location terms and certain medical classifications related to glycogen storage disease.
    Difference
    3%
    Check dated 2025-08-31T11:15:24.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:32:02.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T19:55:42.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has added information about a clinical study evaluating the safety and tolerability of duvoglustat in Pompe disease, including details about the study's design, eligibility criteria, and outcomes. Additionally, the page now includes a disclaimer stating that the U.S. government does not review or approve all studies listed.
    Difference
    100%
    Check dated 2025-08-02T15:23:22.000Z thumbnail image

Stay in the know with updates to AT2220 Safety Study in Pompe Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the AT2220 Safety Study in Pompe Disease Clinical Trial page.